Puma Biotechnology Inc (PBYI) support and resistance · P/E 4.3, rev $56.5M
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
This page maps Puma Biotechnology Inc (PBYI) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PBYI 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PBYI quote page for the session range and the stock page for the full model.
Not investment advice.